New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Read More

New Meds and Tech: Limitations in Supply of Hydrocortisone Tablets – UPDATE

Prepared by: Christine Yu and Amit Lahoti There have been several reports of shortages of Hydrocortisone tablets especially the 5 mg strength in recent months. At…

Read More

New Meds and Tech: Tandem® Diabetes Care Control-IQ Technology

In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…

Read More

New Meds and Tech: New Cortisol Assays, New Threshold for Adrenal Insufficiency

 

Read More

New Meds and Tech: Newer Insulin Preparation – Faster Insulin Aspart (Fiasp)

Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…

Read More

New Meds and Tech: Increlex

In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…

Read More

New Meds and Tech: Glucagon Preparations

The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…

Read More